US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist

2.8500
+0.0100+0.35%

Close Dec 20 16:00 ET

2.9500
+0.1000+3.51%

Post 20:01 ET

192.62MMarket Cap-1.91P/E (TTM)

Perspective Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Perspective Therapeutics Q3 2024 Earnings Date

Currency：USDNov 12, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	237.91K	0	-237.91K
Miss Est.	-87.54%	--	-100.00%
EPS	-0.19	-0.21	-0.02
Miss Est.	+52.14%	+43.24%	-9.72%

Analyst Rating

Strong Buy

Nov 30, 2024

Perspective Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 151.330K	--
--	2024/Q4	-- / 257.760K	--
Nov 12, 2024	2024/Q3	369.000K / 237.910K	--
Aug 12, 2024	2024/Q2	526.000K / 135.630K	--
May 15, 2024	2024/Q1	325.000K / 68.800K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 151.330K--

--2024/Q4-- / 257.760K--

Nov 12, 20242024/Q3369.000K / 237.910K--

Aug 12, 20242024/Q2526.000K / 135.630K--

May 15, 20242024/Q1325.000K / 68.800K--

Unlock Free Earnings Estimates

Open Account

Perspective Therapeutics Earnings Reports

Perspective Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12 16:18 ET

Perspective Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 13 16:10 ET

Perspective Therapeutics | 10-Q: Q1 2024 Earnings Report

May 15 22:44 ET

Perspective Therapeutics | 10-K: FY2023 Annual Report

Mar 28 08:39 ET

Trending US Stocks

Symbol Mini Chart % Chg

Unlock the Full List

Analysis

Analyst Rating

Updated: Nov 30, 2024

Strong Buy

Buy
88.89%
Hold
11.11%
Sell
0.00%

Price Target

No Data